NCT03482076

Brief Summary

Iron deficiency anemia is a common complication of liver cirrhosis in childern and may affects there life this study to improve the outcome of these patients

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 29, 2018

Completed
11 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

March 29, 2018

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

March 23, 2018

Last Update Submit

March 23, 2018

Conditions

Iron Deficiency, Anaemia in ChildrenLiver Cirrhosis

Outcome Measures

Primary Outcomes (1)

  • Prevelance of IDA in liver cirrhosis

    To evaluate results

    two years

Study Arms (1)

transferrin receptor concentration

OTHER

Prevelance of iron deficiency in this patients

Diagnostic Test: transferrin receptor concentration

Interventions

transferrin receptor concentrationDIAGNOSTIC_TEST

Sandwich radio-imunoassay

transferrin receptor concentration

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • all childern with liver cirrhosis in GIT and hepatology unit

You may not qualify if:

  • Neonates less than one month
  • childern with other liver diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Iron DeficienciesLiver Cirrhosis

Condition Hierarchy (Ancestors)

Iron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesLiver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Bahaa Khaled Mohamed

CONTACT

+201002755105drbahaakhaled@gmail.com

Nagla Hassan Ibrahim

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

March 23, 2018

First Posted

March 29, 2018

Study Start

March 1, 2019

Primary Completion

March 1, 2020

Study Completion

June 1, 2020

Last Updated

March 29, 2018

Record last verified: 2018-03